RNTX insider transactions
Rein Therapeutics Inc. (RNTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for RNTX
- Director Von Rickenbach Josef H bought $49,561 worth of Common stock (47,060 units at $1.05), increasing direct ownership by 305% to 62,514 units (SEC Form 4)4 - Rein Therapeutics, Inc. (0001420565) (Issuer)
- Officer Windsor James Brian bought $25,000 worth of Common stock (25,000 units at $1.00), increasing direct ownership by 1,222% to 27,046 units (SEC Form 4)4 - Rein Therapeutics, Inc. (0001420565) (Issuer)
- Large owner Voss Capital, Lp bought $127,593 worth of shares (104,183 units at $1.22) (SEC Form 4)4 - Rein Therapeutics, Inc. (0001420565) (Issuer)
- Large owner Voss Capital, Lp bought $423,466 worth of shares (306,050 units at $1.38) (SEC Form 4)4 - Rein Therapeutics, Inc. (0001420565) (Issuer)
- New insider Voss Capital, Lp claimed ownership of 1,016,208 shares (SEC Form 3)3 - Rein Therapeutics, Inc. (0001420565) (Issuer)
- SEC Form 4 filed by Director Aivado Manuel4 - Rein Therapeutics, Inc. (0001420565) (Issuer)
- SEC Form 4 filed by Director Von Rickenbach Josef H4 - Rein Therapeutics, Inc. (0001420565) (Issuer)
- SEC Form 4 filed by Director Musso Alan A4 - Rein Therapeutics, Inc. (0001420565) (Issuer)
- SEC Form 4 filed by Director Fairey William4 - Rein Therapeutics, Inc. (0001420565) (Issuer)
- SEC Form 4 filed by Director Ambros Reinhard J.4 - Rein Therapeutics, Inc. (0001420565) (Issuer)